PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F13NK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $94,544
Award facts
- Contract value 100% obligated
- $94,543.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $94,543.80 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price contract, with a completion date of January 14, 2026, represents a non-set-aside award made through open competition. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This prime IDC vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally.
AmerisourceBergen's federal contracting activity demonstrates consistent capability in fulfilling government pharmaceutical procurement requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management, and antibiotics. The company serves critical customers within the federal healthcare ecosystem, including the Defense Health Agency, U.S. Coast Guard, and military treatment facilities. This delivery order exemplifies the operational execution under the broader DLA pharmaceutical prime vendor framework, which supports the Department of Defense's medical supply chain operations and strategic planning for next-generation regional pharmaceutical contracts expected to involve multiple award recipients.
Quick answers
Who was awarded contract SPE2D826F13NK?
SPE2D826F13NK was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 13, 2026.
How much is contract SPE2D826F13NK worth?
The government has obligated $94,544 on SPE2D826F13NK.
Is contract SPE2D826F13NK an order under another contract?
Yes. SPE2D826F13NK is a delivery order under SPE2DX22D0029, an indefinite delivery contract.
Was contract SPE2D826F13NK competed?
The extent of competition for SPE2D826F13NK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award